Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationThe International Coalition of Medicines Regulatory Authorities (ICMRA) sets out recommendations to help regulators to address the challenges that the use of artificial intelligence (AI) poses for global medicines regulation, in a report published today.
CTIS Newsletter released
The European Medicines Agency has published for public consultation the ICH guideline Q13 on continuous manufacturing of drug substances and drug products - Step 2b.
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5 August 2021
EMA publishes updated Question and Answer Document on Combination Products
MHRA Access Consortium strategy launched
The UK Early Access to Medicines Scheme (EAMS) is one of the ways through which a patient with a life threatening or seriously debilitating condition can gain access to a medicine before it has gained approval from the UK’s medicines regulatory authority. The MHRA are seeking your views on the proposed legislative changes to clarify the legal basis for EAMS.
MHRA have released the Freedom of Information (FOI) responses for 2021.
MHRA seeks views on innovative medicines manufacture at point of care
Technical transfer of analytical methods, or analytical method transfer (AMT) is a GMP requirement for those involved in contract manufacturing and testing.